VeriMomСтоит ли избегать sassafras officinale bark extract при беременности? | VeriMom
Sassafras bark/root extracts can contain the alkenylbenzene safrole, which is harmonised/classified in the EU as a carcinogen (CLP Category 1B/H350/H351) and is prohibited in cosmetics; carcinogenic/mutagenic hazards are treated as high reproductive concern. Safrole’s metabolic activation leads to DNA adduct formation (demonstrated mechanism). Exposure from topical cosmetic use is low–but measurable unless the extract is guaranteed safrole-free. (ECHA substance data; NTP/Report on Carcinogens; PubMed reviews of alkenylbenzenes).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Безопасен ли sassafras officinale bark extract при беременности?
- Sassafras bark/root extracts can contain the alkenylbenzene safrole, which is harmonised/classified in the EU as a carcinogen (CLP Category 1B/H350/H351) and is prohibited in cosmetics; carcinogenic/mutagenic hazards are treated as high reproductive concern. Safrole’s metabolic activation leads to DNA adduct formation (demonstrated mechanism). Exposure from topical cosmetic use is low–but measurable unless the extract is guaranteed safrole-free. (ECHA substance data; NTP/Report on Carcinogens; PubMed reviews of alkenylbenzenes).
- Безопасен ли sassafras officinale bark extract при грудном вскармливании?
- Same basis as pregnancy: presence of safrole (harmonised EU classification as a CMR) makes the ingredient high hazard for lactation context. Topical exposures are low–but measurable; transfer into milk is not well characterised for cosmetic topical use, but CMR classification and genotoxic mechanism justify a high hazard rating. (ECHA; NTP; SCF/PubMed reviews).
- Безопасен ли sassafras officinale bark extract для кожи малыша?
- Hazard and mechanism mirror adult/pregnancy because safrole is a harmonised CMR 1B. Exposure score is increased for infants (+1) because infant skin has higher surface-area-to-weight and less mature barrier, so a measurable topical exposure becomes a moderate exposure for 0–3 yr. Where the extract is confirmed safrole-free, these scores would change. (ECHA; NTP; PubMed reviews).
- Как VeriMom оценивает sassafras officinale bark extract?
- VeriMom оценивает sassafras officinale bark extract в 20/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы sassafras officinale bark extract при беременности?
- См. наш список безопасных альтернатив sassafras officinale bark extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.